Papers
2
Total Citations
117
H-Index
2
About
S. Hauptmann is a leading gynecologic pathologist whose research has fundamentally shaped the understanding of borderline ovarian tumours (BOT). Her work centers on the clinical behavior, surgical management, and prognostic factors of these complex neoplasms, with a particular focus on how age and surgical staging influence patient outcomes. Through her pivotal contributions to the large-scale AGO ROBOT study, Hauptmann has provided critical evidence that incomplete surgical staging is a negative prognostic factor in serous BOT. Her landmark 2014 study, cited 75 times, demonstrated significant age-dependent differences in BOT characteristics and outcomes, establishing that younger patients have distinct clinical profiles and prognoses compared to older populations. A subsequent 2015 analysis, with 42 citations, further clarified the prognostic impact of individual staging procedures, offering surgeons evidence-based guidance for optimal management. Hauptmann's work has been instrumental in refining risk stratification for BOT patients and has influenced international treatment guidelines. Her meticulous pathological analyses continue to inform clinical decision-making for this challenging tumor type.
Research Focus
Key Achievements
Top Papers
- 1
- 2